Venous Thromboembolism Treatment (VOLT)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/47198
• EU PAS number:
  EUPAS29910
• Study ID:
  47198
• Official title and acronym:
  Venous Thromboembolism Treatment (VOLT)
• DARWIN EU® study:
  No
• Study countries:
  Finland

  Norway

  Sweden
• Study description:
  A retrospective, observational study of patients prescribed an OAC following a VTE event after the 1 January 2013 or the marketing date of NOACs in each country, whichever occurs last, using nationwide registries from multiple Nordic countries (Sweden, Norway, and Finland).
• Study status:
  Ongoing

Research institutions and networks

Institutions

Evidera

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 03/05/2018

Actual: 03/05/2018

Study start date

Planned: 01/07/2019

Actual: 02/12/2019

Date of final study report

Planned: 30/06/2023

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

BMS/Pfizer

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

B0661132